Karamba
Karamba, licence 80035308: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Gourmet Nutrition F.B. Inc.
- NPN or DIN-HM
- 80035308
- Status
- Active licence
- Licence date
- 7 September 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 18 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Gluconate de zinc | 6.0 mg | 18,000 µg |
| Panax ginseng Source : Racine Extraction ratio : 4.0:1 Dry plant equivalent : 600 mg Potency : 7.0 % Ginsénosides au total | 150.0 mg | Not calculated |
| Eurycoma Longifolia Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 20 mg | 2.0 mg | Not calculated |
| Schisandra chinensis Source : Fruit Extraction ratio : 5.0:1 Dry plant equivalent : 50 mg | 10.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | minimum: 2.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Utilisé en phytothérapie pour aider au maintien des fonctions cognitives et/ou à la réduction de fatigue mentale, pour aider à accroître les capacités physiques/la performance physique et comme thérapie de soutien pour aider au contrôle du taux de glucose. Aide au maintien des fonctions immunitaires.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Des symptômes d'insomnie, d'anxiété, ou de maux de tête pourraient apparaître chez les personnes sensibles. Si tel est le cas, cesser l'utilisation. Peut provoquer des réactions indésirables chez les personnes allergiques aux plantes de la famille de la moutarde (Brassicacées).
Source
Official Health Canada record, licence 80035308
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.